Patents by Inventor Mohammed I. Dibas

Mohammed I. Dibas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(IMIDAZOLIDIN-2-YLIDENE)QUINOLINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
    Publication number: 20130029994
    Abstract: The present invention relates to novel N-(imidazolidin-2-ylidene)quinoline derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: July 20, 2012
    Publication date: January 31, 2013
    Inventors: Santosh C. Sinha, Liming Wang, Ken Chow, Mohammed I. Dibas, Michael E. Garst
  • PHARMACEUTICAL COMPOSITIONS COMPRISING 4-BROMO-N-(IMIDAZOLIDIN-2-YLIDENE)-1H-BENZIMIDAZOL-5-AMINE FOR TREATING SKIN DISEASES
    Publication number: 20130023572
    Abstract: The present invention relates to a method for treating skin diseases in a patient in need thereof which comprises of administering a pharmaceutical composition comprising a therapeutically effective amount of 4-bromo-N-(imidazolidin-2-ylidene)-1H-benzimidazol-5-amine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
    Type: Application
    Filed: July 18, 2012
    Publication date: January 24, 2013
    Inventors: Mohammed I. Dibas, John E. Donello, Daniel W. Gil
  • ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES
    Publication number: 20120149746
    Abstract: The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: September 15, 2011
    Publication date: June 14, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Mohammed I. Dibas, Daniel W. Gil, Ken Chow, Liming Wang, Michael E. Garst, John E. Donello
  • ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE
    Publication number: 20120142746
    Abstract: The present invention relates to method of lowering intraocular pressure in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, of enantiomers thereof, of tautomers thereof, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: September 15, 2011
    Publication date: June 7, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Mohammed I. Dibas, Daniel W. Gil, John E. Donello, Ken Chow, Liming Wang, Michael E. Garst
  • ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND CONDITIONS
    Publication number: 20120136036
    Abstract: The present invention relates to method for treating skin diseases and skin conditions in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, or enantiomers thereof, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: September 15, 2011
    Publication date: May 31, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Mohammed I. Dibas, Ken Chow, Liming Wang, Michael E. Garst, John E. Donello, Daniel W. Gil
  • S1P3 Receptor Inhibitors for Treating Conditions of the Eye
    Publication number: 20120071448
    Abstract: Disclosed herein are compositions and methods for treating conditions of the eye using S1P3 receptor inhibitors.
    Type: Application
    Filed: May 4, 2010
    Publication date: March 22, 2012
    Applicant: Allergan, Inc.
    Inventors: John E. Donello, Richard L. Beard, Mohammed I. Dibas
  • S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION
    Publication number: 20110009453
    Abstract: Disclosed herein are compositions and methods for treating inflammation using S1 P3 receptor inhibitors.
    Type: Application
    Filed: March 16, 2009
    Publication date: January 13, 2011
    Inventors: John E. Donello, Mohammed I. Dibas